CMEM News & Announcements

Douglas C. Wallace, PhD, investigates the role of adaptive immunity in the etiology of Alzheimer’s disease (AD) and AD-related dementias.

The FDA approved an oral drug, based on foundational research conducted at CHOP, to treat a rare, severe bone disease. More In The News.

While mitochondrial function recovered in the lungs, function did not recover in the heart and other organs, leading to long-term damage and a possible explanation for detrimental effects of “long COVID.”

With a grant from the Gates Foundation, CHOP researchers are working to determine the importance of mitochondria DNA variation in COVID-19 severity.

Featured Diversity Fellow Arnold Olali, PhD, is focused on understanding how mitochondria affect overall health.

A U.S. Department of Defense grant will support CHOP researchers in their study of noninvasive methods to diagnose mitochondrial diseases.

Learn about novel findings from our Children’s Hospital of Philadelphia researchers.

New study shows how nicotimamide riboside, part of the vitamin B3 family, could mitigate myopathy caused by a genetic variant.

Read about the latest discoveries and awards at Children’s Hospital of Philadelphia Research Institute.

The mitochondrial genetic status of patients should be considered when recommending exercise as therapy.

The Center for Mitochondrial and Epigenomic Medicine will be awarding two research grants of $25,000 each for the period of January 1, 2022

Findings support lysosomal acidification strategies for pediatric neurodegenerative disorders with impaired mitochondrial quality control.

CHOP and Penn researchers find connection between mitochondrial function and mental illness in patients with a rare genetic disorder.

The results of the study may eventually lead to targeted prevention and treatment strategies for patients with the condition.

Discover new findings about COVID-19 testing before surgery, the link between mitochondria and autism, and how neighborhoods affect sleep.

Autism spectrum disorder may be caused by defects in the mitochondria of brain cells, according to new research published online in PNAS.

Request for applications for four $25,000 grants: Center for Mitochondrial and Epigenomic Research (CMEM)